BridgeMD
New treatment option for Type 1 Diabetes
Official title Family Intervention for Black Teens With Type 1 Diabetes
ClinicalTrials.gov ID: NCT06275412
What this study is testing
- What it's testing
- The purpose of this study is to conduct a multicenter, randomized effectiveness trial of The 3Ms 2.0 compared to an educational control condition for improving adolescent glycemic control and diabetes-related family relationships and reducing primary caregiver diabetes-related distress among Black adolescents with type 1 diabetes (T1D) and their primary caregivers. The proposed study would develop and test The 3Ms 2.0 adapted intervention when delivered using a mobile health approach (accessed via parents' cell phone).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 10 to 14
You may be able to join if
- Age: 10 years, 0 months - 14 years, 11 months
- Diagnosed with Type 1 diabetes
- Diagnosed for at least 6 months
- Black
- Primary caregiver willing to participate
You likely can't join if
- Mental health conditions that might compromise data integrity (e.g., developmental delay, schizophrenia, psychosis, current suicidality, homicidality)
- Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis)
- Inability to speak or read English
- Child is in out-of-home placement
See the full eligibility criteria
- Age: 10 years, 0 months - 14 years, 11 months
- Diagnosed with Type 1 diabetes
- Diagnosed for at least 6 months
- Black
- Primary caregiver willing to participate
- Residence within 30 miles of a recruitment site
- Caregiver ownership of an Internet-enabled device (cell phone, laptop or desktop computer, tablet, etc)
- Mental health conditions that might compromise data integrity (e.g., developmental delay, schizophrenia, psychosis, current suicidality, homicidality)
- Co-morbid medical condition resulting in atypical diabetes management (e.g., cystic fibrosis)
- Inability to speak or read English
- Child is in out-of-home placement
The study team makes the final eligibility decision.
Where it's taking place
- Washington D.C., District of Columbia, United States
- Detroit, Michigan, United States
- Memphis, Tennessee, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 10 years to 14 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Washington D.C., District of Columbia, United States; Detroit, Michigan, United States; Memphis, Tennessee, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.